Treatment-Resistant Depression NFZ — 56 facilities in 53 cities

Treatment-resistant depression is a severe form of depression that does not respond to at least two adequate antidepressant treatment courses. The NFZ covers psychiatric evaluation, psychotherapy, advanced pharmacological regimens including lithium augmentation, and intranasal esketamine through a drug program. Transcranial stimulation and electroconvulsive therapy are also available for eligible patients.